Viatris Inc
NASDAQ:VTRS
Viatris Inc
Deferred Income Tax
Viatris Inc
Deferred Income Tax Peer Comparison
Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors
Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Viatris Inc
NASDAQ:VTRS
|
Deferred Income Tax
$1.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
0%
|
CAGR 10-Years
14%
|
|
Johnson & Johnson
NYSE:JNJ
|
Deferred Income Tax
$3.2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-4%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Deferred Income Tax
$442m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
Pfizer Inc
NYSE:PFE
|
Deferred Income Tax
$931m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-28%
|
|
Merck & Co Inc
NYSE:MRK
|
Deferred Income Tax
$922m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-17%
|
|
Eli Lilly and Co
NYSE:LLY
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Viatris Inc's Deferred Income Tax?
Deferred Income Tax
1.7B
USD
Based on the financial report for Mar 31, 2024, Viatris Inc's Deferred Income Tax amounts to 1.7B USD.
What is Viatris Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
14%
Over the last year, the Deferred Income Tax growth was -32%. The average annual Deferred Income Tax growth rates for Viatris Inc have been -18% over the past three years , and 14% over the past ten years .